News

Experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung disease
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...
Science Daily1d
Experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung disease, study suggests
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...
News Medical on MSN3d
Study Suggests Experimental Cancer Drug Could Streamline Standard Tuberculosis Treatment and Prevent Post-TB Lung Disease
In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...
EurekAlert!3d
Study suggests experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung disease
TB is caused by Mycobacterium tuberculosis, a type of bacterial species. In early stages, infected lung cells limit spread ... and damage to surrounding tissue. While apoptosis could be compared ...
News Medical3d
Experimental cancer drug shows promise in boosting tuberculosis treatment
TB is caused by Mycobacterium tuberculosis, a type of bacterial species. In early stages, infected lung cells limit spread ... and damage to surrounding tissue. While apoptosis could be compared ...
The Tufts Daily15d
Tuberculosis outbreak in Kansas City
When an individual becomes infected with tuberculosis, the bacteria most commonly spread to the lungs, replicate and form large masses called tubercles. These tubercles can break down lung tissue and ...